These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 412527)

  • 21. Studies of MAO concentration and activity in schizophrenic patients.
    Abell CW; Fritz RB; Landowski J; Bessman JD; Castellani S; Boeringa JA; Rose RM
    Prog Clin Biol Res; 1982; 79():209-21. PubMed ID: 7088965
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelet MAO Vmax and Km in chronic schizophrenic subjects.
    Giller EL; Bierer L; Rubinow D; Docherty JP
    Am J Psychiatry; 1980 Jan; 137(1):97-8. PubMed ID: 7352569
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives, and controls.
    Nies A; Robinson DS; Harris LS; Lamborn KR
    Adv Biochem Psychopharmacol; 1974; 12(0):59-70. PubMed ID: 4607593
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood platelet monoamine oxidase activity in psychiatric patients.
    Friedman E; Shopsin B; Sathananthan G; Gershon S
    Am J Psychiatry; 1974 Dec; 131(12):1392-4. PubMed ID: 4432940
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for an endogenous inhibitor of platelet MAO in chronic schizophrenia.
    Berrettini WH; Vogel WH
    Am J Psychiatry; 1978 May; 135(5):605-7. PubMed ID: 645960
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of oral glucose on platelet monoamine oxidase.
    Karson CN; Bridge TP; Phelps BH; Wise CD; Potkin SG; Apostoles PS; Wyatt RJ
    Biol Psychiatry; 1982 Sep; 17(9):1011-5. PubMed ID: 7138991
    [No Abstract]   [Full Text] [Related]  

  • 27. d-Amphetamine raises cortisol levels in schizophrenic patients with and without chronic naltrexone pretreatment.
    van Kammen DP; Schulz SC
    J Neural Transm; 1985; 64(1):35-43. PubMed ID: 4067601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of mouse brain monoamine oxidase by (+)-amphetamine in vivo.
    Green AL; el Hait MA
    J Pharm Pharmacol; 1978 Apr; 30(4):262-3. PubMed ID: 24723
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet methylene reductase activity in schizophrenia.
    Berger PA; Elliott GR; Erdelyi E; Watson SJ; Wyatt RJ; Barchas JD
    Arch Gen Psychiatry; 1977 Jul; 34(7):808-9. PubMed ID: 879976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine and nitric oxide interaction on the modulation of prepulse inhibition of the acoustic startle response in the Wistar rat.
    Salum C; Guimarães FS; Brandão ML; Del Bel EA
    Psychopharmacology (Berl); 2006 Apr; 185(2):133-41. PubMed ID: 16402193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. d-amphetamine inhibition of platelet MAO from schizophrenic patients.
    Reches A; Ebstein RP; Belmaker RH
    Biol Psychiatry; 1977 Oct; 12(5):655-9. PubMed ID: 412527
    [No Abstract]   [Full Text] [Related]  

  • 32. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population.
    Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ
    Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The study of the platelet monoamine oxidase activity in chronic schizophrenic patients (author's transl)].
    Shohmori T; Kaneyuki T; Doi T; Mitani K; Kohsaka M
    Seishin Shinkeigaku Zasshi; 1977 Oct; 79(10):563-7. PubMed ID: 607254
    [No Abstract]   [Full Text] [Related]  

  • 34. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The preliminary study of monoamine oxidase activity in platelets in patients with schizophrenia and affective disorder].
    Lin Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):325-7, 382. PubMed ID: 1304991
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.